126 related articles for article (PubMed ID: 28757552)
1. Effects of P-Glycoprotein on the Transport of DL0410, a Potential Multifunctional Anti-Alzheimer Agent.
Pang X; Wang L; Kang D; Zhao Y; Wu S; Liu AL; Du GH
Molecules; 2017 Jul; 22(8):. PubMed ID: 28757552
[TBL] [Abstract][Full Text] [Related]
2. Effects of P-glycoprotein on the intestine and blood-brain barrier transport of YZG-331, a promising sedative-hypnotic compound.
Liu Z; Mi J; Yang S; Zhao M; Li Y; Sheng L
Eur J Pharmacol; 2016 Nov; 791():339-347. PubMed ID: 27612629
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Drug Transport in MDCKII-Wild Type, MDCKII-MDR1, MDCKII-BCRP and Caco-2 Cell Lines.
Mukkavilli R; Jadhav G; Vangala S
Curr Pharm Biotechnol; 2017; 18(14):1151-1158. PubMed ID: 29521222
[TBL] [Abstract][Full Text] [Related]
4. Molecular pharmacokinetic mechanism of the drug-drug interaction between genistein and repaglinide mediated by P-gp.
Jin H; Zhu Y; Wang C; Meng Q; Wu J; Sun P; Ma X; Sun H; Huo X; Liu K; Tan A
Biomed Pharmacother; 2020 May; 125():110032. PubMed ID: 32187961
[TBL] [Abstract][Full Text] [Related]
5. Functional assessment of multiple P-glycoprotein (P-gp) probe substrates: influence of cell line and modulator concentration on P-gp activity.
Taub ME; Podila L; Ely D; Almeida I
Drug Metab Dispos; 2005 Nov; 33(11):1679-87. PubMed ID: 16093365
[TBL] [Abstract][Full Text] [Related]
6. In vitro assessment of the interactions of dopamine β-hydroxylase inhibitors with human P-glycoprotein and Breast Cancer Resistance Protein.
Bicker J; Alves G; Fortuna A; Soares-da-Silva P; Falcão A
Eur J Pharm Sci; 2018 May; 117():35-40. PubMed ID: 29428540
[TBL] [Abstract][Full Text] [Related]
7. Reversal Effect of Oxypeucedanin on P-glycoprotein-mediated Drug Transport.
Dong W; Liao ZG; Zhao GW; Guan XJ; Zhang J; Liang XL; Yang M
Molecules; 2018 Jul; 23(8):. PubMed ID: 30042338
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model.
Karyekar CS; Eddington ND; Garimella TS; Gubbins PO; Dowling TC
Pharmacotherapy; 2003 Apr; 23(4):436-42. PubMed ID: 12680473
[TBL] [Abstract][Full Text] [Related]
9. Aristolochic acid I is a substrate of BCRP but not P-glycoprotein or MRP2.
Ma L; Qin Y; Shen Z; Bi H; Hu H; Huang M; Zhou H; Yu L; Jiang H; Zeng S
J Ethnopharmacol; 2015 Aug; 172():430-5. PubMed ID: 26183576
[TBL] [Abstract][Full Text] [Related]
10. Screening of pharmacokinetic properties of fifty dihydropyrimidin(thi)one derivatives using a combo of in vitro and in silico assays.
Matias M; Fortuna A; Bicker J; Silvestre S; Falcão A; Alves G
Eur J Pharm Sci; 2017 Nov; 109():334-346. PubMed ID: 28842351
[TBL] [Abstract][Full Text] [Related]
11. In Silico and in Vitro Screening for P-Glycoprotein Interaction with Tenofovir, Darunavir, and Dapivirine: An Antiretroviral Drug Combination for Topical Prevention of Colorectal HIV Transmission.
Swedrowska M; Jamshidi S; Kumar A; Kelly C; Rahman KM; Forbes B
Mol Pharm; 2017 Aug; 14(8):2660-2669. PubMed ID: 28648081
[TBL] [Abstract][Full Text] [Related]
12. In vitro characterization of axitinib interactions with human efflux and hepatic uptake transporters: implications for disposition and drug interactions.
Reyner EL; Sevidal S; West MA; Clouser-Roche A; Freiwald S; Fenner K; Ullah M; Lee CA; Smith BJ
Drug Metab Dispos; 2013 Aug; 41(8):1575-83. PubMed ID: 23729661
[TBL] [Abstract][Full Text] [Related]
13. Improvement of Transmembrane Transport Mechanism Study of Imperatorin on P-Glycoprotein-Mediated Drug Transport.
Liao ZG; Tang T; Guan XJ; Dong W; Zhang J; Zhao GW; Yang M; Liang XL
Molecules; 2016 Nov; 21(12):. PubMed ID: 27886150
[TBL] [Abstract][Full Text] [Related]
14. Periplocymarin is a potential natural compound for drug development: highly permeable with absence of P-glycoprotein efflux and cytochrome P450 inhibitions.
Martey ON; He X; Xing H; Deng F; Feng S; Li C; Shi X
Biopharm Drug Dispos; 2014 May; 35(4):195-206. PubMed ID: 24424534
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of blood-brain barrier and blood-cerebrospinal fluid barrier permeability of 2-phenoxy-indan-1-one derivatives using in vitro cell models.
Hu HH; Bian YC; Liu Y; Sheng R; Jiang HD; Yu LS; Hu YZ; Zeng S
Int J Pharm; 2014 Jan; 460(1-2):101-7. PubMed ID: 24262988
[TBL] [Abstract][Full Text] [Related]
16. Comparison of MDCK-MDR1 and Caco-2 cell based permeability assays for anti-malarial drug screening and drug investigations.
Jin X; Luong TL; Reese N; Gaona H; Collazo-Velez V; Vuong C; Potter B; Sousa JC; Olmeda R; Li Q; Xie L; Zhang J; Zhang P; Reichard G; Melendez V; Marcsisin SR; Pybus BS
J Pharmacol Toxicol Methods; 2014; 70(2):188-94. PubMed ID: 25150934
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intestinal permeability and p-glycoprotein effects on the intestinal absorption of enantiomers of 2-(2-hydroxypropanamido) benzoic acid in rats.
Zhang Q; Zhang M; Wang D; Zhao Y; Yu Z
Chirality; 2017 Jan; 29(1):26-32. PubMed ID: 27992072
[TBL] [Abstract][Full Text] [Related]
18. Elucidation of the Impact of P-glycoprotein and Breast Cancer Resistance Protein on the Brain Distribution of Catechol-
Bicker J; Fortuna A; Alves G; Soares-da-Silva P; Falcão A
Drug Metab Dispos; 2017 Dec; 45(12):1282-1291. PubMed ID: 28916530
[TBL] [Abstract][Full Text] [Related]
19. Elucidation of Transport Mechanism of Paeoniflorin and the Influence of Ligustilide, Senkyunolide I and Senkyunolide A on Paeoniflorin Transport through Mdck-Mdr1 Cells as Blood-Brain Barrier in Vitro Model.
Hu PY; Liu D; Zheng Q; Wu Q; Tang Y; Yang M
Molecules; 2016 Mar; 21(3):300. PubMed ID: 26950101
[TBL] [Abstract][Full Text] [Related]
20. pH Dependent but not P-gp Dependent Bidirectional Transport Study of S-propranolol: The Importance of Passive Diffusion.
Zheng Y; Benet LZ; Okochi H; Chen X
Pharm Res; 2015 Aug; 32(8):2516-26. PubMed ID: 25690341
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
